title: Use of activated charcoal to reduce elevated serum phenobarbital concentration in a neonate.
abstract: The course of a neonate administered activated charcoal orally for elevated phenobarbital concentration is described. The neonate required a serum concentration of phenobarbital eventually exceeding 80 micrograms/mL for seizure control. However, due to the severe CNS injury as a result of the asphyxia at birth, a diagnosis of cerebral death by electroencephalogram and apnea test was pursued. This required the phenobarbital concentration to be less than 30 micrograms/mL. Serial phenobarbital concentrations during this time indicated a 250 hour half-life, which would require two weeks for the phenobarbital to drop below 30 micrograms/mL. With the administration of six doses of activated charcoal at 0.7 g/kg/dose, the phenobarbital serum concentration decreased to 22 micrograms/mL, giving an estimated phenobarbital half-life of 22 hours. This, and two other subsequent cases, indicates repeated doses of activated charcoal are effective in augmenting the clearance of certain drugs in the neonatal age group.
authors.affiliation: Department of Pharmacy, Shands Hospital, Gainesville, Florida.
authors.forename: M
authors.initials: M
authors.lastname: Veerman
authors.forename: M G
authors.initials: MG
authors.lastname: Espejo
authors.forename: M A
authors.initials: MA
authors.lastname: Christopher
authors.forename: M
authors.initials: M
authors.lastname: Knight
mesh_terms: D000284:Administration, Oral; D001238:Asphyxia Neonatorum / Q000150:complications; D002606:Charcoal / Q000008:administration & dosage / Q000627:therapeutic use*; D006207:Half-Life; D006801:Humans; D007231:Infant, Newborn; D008297:Male; D010634:Phenobarbital / Q000097:blood* / Q000627:therapeutic use; D012640:Seizures / Q000188:drug therapy / Q000209:etiology
chemical_list: D002606:Charcoal; D010634:Phenobarbital